» Articles » PMID: 2382828

Automated Enzymatic Measurement of Adenosine Deaminase Isoenzyme Activities in Serum

Overview
Journal Anal Biochem
Publisher Elsevier
Specialty Biochemistry
Date 1990 Jun 1
PMID 2382828
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

We developed a simple, rapid, and automated method for simultaneous measurement of adenosine deaminase (ADA, EC 3.5.4.4) isoenzymes in human serum, based on their apparent difference in Ki values for erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) as inhibitor. Serum ADA was partially purified by CM-Sephadex, gel-filtration, and affinity chromatography into two types of isoenzymes, designated ADA1 (300 kDa) and ADA2 (120 kDa). Because ADA2 has a higher Km for adenosine and higher Ki values for EHNA than does ADA1, the activity of ADA1 is almost completely inhibited by EHNA at 0.1 mM (analytical recovery 4.1%), whereas ADA2 is practically unaffected (analytical recovery 94.8%) by that concentration of EHNA. We measured the activities of ADA2 and total ADA in the presence and absence of 0.1 mM EHNA. ADA1 activities were calculated by subtracting the activity of ADA2 from that of total ADA. The mean within-assay CV was 5.7% for ADA1 and 2.7% for ADA2. The interassay CV was 2.8% for ADA1 and 3.1% for ADA2. Results of the present method correlated well (r = 0.9026 for ADA1, 0.9438 for ADA2) with those of the ion-exchange chromatography method. The upper limits of the reference intervals, as calculated from data for 320 healthy donors, are 7.2 U/liter for ADA1, and 14.6 U/liter for ADA2. This method is suitable for analysis of large numbers of samples in clinical laboratories for routine monitoring of the activities of ADA isoenzymes in serum.

Citing Articles

Measurement of New Biomarkers of Immunity and Welfare in Colostrum and Milk of Pigs: Analytical Validation and Changes During Lactation.

Botia M, Escribano D, Mainau E, Munoz-Prieto A, Ceron J Biology (Basel). 2024; 13(10).

PMID: 39452138 PMC: 11503992. DOI: 10.3390/biology13100829.


Adenosine Deaminase 2 Deficiency (DADA2): A Crosstalk Between Innate and Adaptive Immunity.

Signa S, Bertoni A, Penco F, Caorsi R, Cafaro A, Cangemi G Front Immunol. 2022; 13:935957.

PMID: 35898506 PMC: 9309328. DOI: 10.3389/fimmu.2022.935957.


Lentiviral Mediated Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2.

Hong Y, Casimir M, Houghton B, Zhang F, Jensen B, Omoyinmi E Front Immunol. 2022; 13:852830.

PMID: 35529868 PMC: 9073084. DOI: 10.3389/fimmu.2022.852830.


Changes of adenosine deaminase activity in serum and saliva around parturition in sows with and without postpartum dysgalactia syndrome.

Kaiser M, Dahl J, Jacobsen S, Jacobson M, Andersen P, Baekbo P BMC Vet Res. 2021; 17(1):352.

PMID: 34794425 PMC: 8600890. DOI: 10.1186/s12917-021-03067-6.


Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.

Delemarre E, van Hoorn L, Bossink A, Drylewicz J, Joosten S, Ottenhoff T Front Immunol. 2021; 12:725447.

PMID: 34691031 PMC: 8529994. DOI: 10.3389/fimmu.2021.725447.